Molecular genetic studies in muscle phosphoglycerate mutase (PGAM-M) deficiency

Muscle Nerve Suppl. 1995:3:S50-3. doi: 10.1002/mus.880181412.

Abstract

Phosphoglycerate mutase (PGAM; EC 2.7.5.3) catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglycerate in the glycolytic pathway. Hereditary muscle PGAM deficiency has been identified in 9 patients with myopathy. All patients had exercise intolerance and 6 had myoglobinuria. Seven of the 9 patients were African-Americans: 5 of them were homozygous for a nonsense mutation, TGG(Trp) to TAG at codon 78; 1 was a compound heterozygote for the nonsense mutation and a missense mutation, GAG(Glu) to GCG(Ala) at codon 89; and 1 could not be tested. The only 2 Caucasian patients, a brother and sister, were homozygous for a different missense mutation, CGG(Arg) to TGG(Trp) at codon 90. Despite the small number of patients identified, these findings indicate that there is a common mutation in African-Americans while there may be molecular genetic heterogeneity in other ethnic groups.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Black People
  • Black or African American
  • Child
  • Female
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Muscles / enzymology*
  • Mutation*
  • Phosphoglycerate Mutase / deficiency*
  • Phosphoglycerate Mutase / genetics*

Substances

  • Phosphoglycerate Mutase